Skip to main content
Ir a la página de inicio de la Comisión Europea (se abrirá en una nueva ventana)
español es
CORDIS - Resultados de investigaciones de la UE
CORDIS

Decoding tumour-immune interactions and the evolutionary trajectories of complex genomic rearrangements in highly aggressive cancers

Objetivo

Cancer genomes are riddled by remarkably complex forms of structural variants collectively known as complex genomic rearrangements (CGRs). Our previous work showed that CGRs occur at high frequency in some of the deadliest cancers in humans and underpin drug resistance and poor prognosis. Yet, the impact of CGRs on immune escape, cancer cell plasticity, metastasis, drug resistance and clonal evolution remains elusive. As a result, we have not been able to deliver eagerly awaited breakthroughs for the treatment of tumours driven by CGRs.
In this ERC project, I aim to change the paradigm for cancer therapy development for tumours driven by CGRs. To this aim, BrokenChromosomes will first rely on a multi-disciplinary approach combining spatially resolved multi-omic profiling of tumours to elucidate the mechanisms whereby CGRs shape the tumour-immune microenvironment to achieve immune escape and modulate cancer cell fitness and plasticity during tumour evolution and metastatic spread, which might open new therapeutic avenues to treat currently incurable cancers driven by CGRs. Second, we will study the differentiation dynamics and phenotypes of neoantigen-specific tumour-infiltrating T cells in tumours showing high rates of CGRs, and we will assess their tumour-killing activity using patient-derived ex vivo tumour-immune co-cultures. By assessing the immunogenicity of diverse mutations in tumours driven by CGRs, I aim to provide critical new knowledge to enable the development of therapeutic breakthroughs for these tumours using immunotherapies. Finally, we will decode the interplay between epigenetic dysregulation at centromeres, chromosomal instability and CGR formation, which might also have far-reaching implications beyond cancer by explaining why e.g. increased rates of aneuploidy in healthy cells, e.g. oocytes, is an age-dependent process.

Ámbito científico (EuroSciVoc)

Palabras clave

Programa(s)

Tema(s)

Régimen de financiación

HORIZON-ERC - HORIZON ERC Grants

Ver todos los proyectos financiados en el marco de este régimen de financiación

Convocatoria de propuestas

(se abrirá en una nueva ventana) ERC-2025-COG

Ver todos los proyectos financiados en el marco de esta convocatoria

Institución de acogida

THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD
Aportación neta de la UEn
€ 1 999 682,00
Dirección
WELLINGTON SQUARE UNIVERSITY OFFICES
OX1 2JD Oxford
Reino Unido
Región
South East (England) Berkshire, Buckinghamshire and Oxfordshire Oxfordshire
Tipo de actividad
Higher or Secondary Education Establishments
Enlaces
Coste total
€ 1 999 682,00

Beneficiarios (1)